 |
 |

Frontotemporal Lobar Degeneration
Demographic Characteristics of 353 Patients
Julene K. Johnson, PhD;
Janine Diehl, MD;
Mario F. Mendez, MD, PhD;
John Neuhaus, PhD;
Jill S. Shapira, RN, PhD;
Mark Forman, MD, PhD;
Dennis J. Chute, MD;
Erik D. Roberson, MD, PhD;
Catherine Pace-Savitsky, MA;
Manuela Neumann, MD;
Tiffany W. Chow, MD;
Howard J. Rosen, MD;
Hans Forstl, MD;
Alexander Kurz, MD;
Bruce L. Miller, MD
Arch Neurol. 2005;62:925-930.
Background Until recently, frontotemporal lobar degeneration (FTLD) was considered a rare neurodegenerative disorder that was difficult to diagnose. The publication of consensus criteria for FTLD, however, prompted systematic studies. The criteria categorize FTLD into 3 subgroups: frontotemporal dementia, semantic dementia, and progressive nonfluent aphasia.
Objective To compare demographic characteristics of patients in the 3 FTLD subgroups.
Design We compared diagnostic breakdown, age at onset, sex, Mini-Mental State Examination score at first visit, education, and neuropathological diagnoses in a large sample of FTLD patients from 3 different university dementia clinics, including 2 neurologic clinics in the United States and 1 psychiatric clinic in Germany.
Results The frontotemporal dementia subgroup represented approximately half of all FTLD diagnoses. Patients diagnosed as having frontotemporal dementia (mean age, 57.5 years) and semantic dementia (mean age, 59.3 years) had an earlier age at onset than patients diagnosed as having progressive nonfluent aphasia (mean age, 63.0 years). There were significantly more men diagnosed as having frontotemporal dementia (63.5%) and semantic dementia (66.7%) when compared with progressive nonfluent aphasia (39.1%) (P = .005 for frontotemporal dementia vs progressive nonfluent aphasia and P = .002 for semantic dementia vs progressive nonfluent aphasia). Generally, the demographic features and diagnostic categories of the patient populations across the 3 sites were comparable. There were 68 deaths and 37 autopsies. Frontotemporal lobar degeneration with ubiquitin-positive -negative inclusions (48.5%), dementia lacking distinctive histopathological features (18.2%), and Pick disease (15.2%) were the most common neuropathological diagnoses.
Conclusions These findings show that cohorts of patients can be combined using new research criteria for FTLD and demonstrate striking demographic differences among FTLD subgroups. The sex and age-at-onset differences suggest that there may be biological differences among FTLD subgroups. In this sample, FTLD with ubiquitin-positive inclusions accounted for half of all neuropathological diagnoses.
Author Affiliations: Departments of Neurology (Drs Johnson, Roberson, Rosen, and Miller and Ms Pace-Savitsky) and Biostatistics (Dr Neuhaus) and Gladstone Institute of Neurological Disease (Dr Roberson), University of California, San Francisco; Technische Universität Munich, Munich, Germany (Drs Diehl, Forstl, and Kurz); Departments of Neurology (Drs Mendez and Shapira) and Pathology and Laboratory Medicine (Dr Chute), University of California, Los Angeles; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia (Dr Forman); Center for Neuropathology and Prion Research, Ludwig Maximilians University, Munich (Dr Neumann); and The Rotman Research Institute of Baycrest Centre for Geriatric Care, University of Toronto, Toronto, Ontario (Dr Chow).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
A new subtype of frontotemporal lobar degeneration with FUS pathology
Neumann et al.
Brain 2009;132:2922-2931.
ABSTRACT
| FULL TEXT
TDP-43 in Cerebrospinal Fluid of Patients With Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Steinacker et al.
Arch Neurol 2008;65:1481-1487.
ABSTRACT
| FULL TEXT
Distinct genetic forms of frontotemporal dementia
Seelaar et al.
Neurology 2008;71:1220-1226.
ABSTRACT
| FULL TEXT
Measuring progression in frontotemporal dementia: Implications for therapeutic interventions
Kipps et al.
Neurology 2008;70:2046-2052.
ABSTRACT
| FULL TEXT
An Evidence-Based Review of the Psychopathology of Frontotemporal Dementia: A Report of the ANPA Committee on Research
Mendez et al.
J. Neuropsychiatry Clin. Neurosi. 2008;20:130-149.
ABSTRACT
| FULL TEXT
Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions
Mackenzie et al.
Brain 2008;131:1282-1293.
ABSTRACT
| FULL TEXT
TDP-43 Proteinopathy in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis: Protein Misfolding Diseases Without Amyloidosis
Neumann et al.
Arch Neurol 2007;64:1388-1394.
ABSTRACT
| FULL TEXT
Clinicopathologic correlation in PGRN mutations
Davion et al.
Neurology 2007;69:1113-1121.
ABSTRACT
| FULL TEXT
Patterns of Atrophy Differ Among Specific Subtypes of Mild Cognitive Impairment
Whitwell et al.
Arch Neurol 2007;64:1130-1138.
ABSTRACT
| FULL TEXT
TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without Progranulin mutations
Seelaar et al.
Brain 2007;130:1375-1385.
ABSTRACT
| FULL TEXT
Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia.
Ber et al.
Brain 2006;129:3051-3065.
ABSTRACT
| FULL TEXT
The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene.
Mackenzie et al.
Brain 2006;129:3081-3090.
ABSTRACT
| FULL TEXT
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Neumann et al.
Science 2006;314:130-133.
ABSTRACT
| FULL TEXT
Pathological Heterogeneity of Frontotemporal Lobar Degeneration with Ubiquitin-Positive Inclusions Delineated by Ubiquitin Immunohistochemistry and Novel Monoclonal Antibodies
Sampathu et al.
Am. J. Pathol. 2006;169:1343-1352.
ABSTRACT
| FULL TEXT
Self-conscious emotion deficits in frontotemporal lobar degeneration
Sturm et al.
Brain 2006;129:2508-2516.
ABSTRACT
| FULL TEXT
A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD
van der Zee et al.
Brain 2006;129:841-852.
ABSTRACT
| FULL TEXT
|